ProShares - Nasdaq-100 Dynamic Buffer ETF

QB

NASDAQ Global Select·Equity

Open in GoAI

Share

At close

$48.63

−$0.055 · -0.11%

Sep 10, 4:00 PM ET

After-hours

$48.63

$0.00 · 0.00%

Sep 10, 4:04 PM ET

QB ETF overview

1D5D1M3M6MYTD1Y5YALL

LineCandlestick

Volume

Regular session · ET · Market data may be delayed.

About this ETF

Fund website

An exchange-traded fund (ETF) offered by ProShares, which provides dynamically buffered exposure to the Nasdaq-100 index.

Asset class

Equity

Issuer

ProShares

Domicile

US

Inception date

Jun 24, 2025

Holdings

103

ISIN

US74349Y5978

Key fund statistics

Fund assets

3.41M USD

Expense ratio

0.58%

NAV

$48.68

Average volume

4.34K

Volume

184

Day range

$48.61 – $48.63

52-week range

$40.86 – $49.24

Previous close

$48.685

Price change

Performance

1 day

-0.11%

1 month

-0.23%

3 months

+7.54%

Year to date

+14.94%

1 year

+18.93%

3 years

+21.00%

5 years

+21.00%

Price changes exclude distributions, fees, taxes, and investor-specific cash flows.

Portfolio composition

Exposure

Sector exposure

Top 10

Technology59.90%

Communication Services12.35%

Consumer Cyclical10.48%

Consumer Defensive6.20%

Industrials4.24%

Healthcare4.03%

Utilities1.17%

Basic Materials0.98%

Energy0.52%

Financial Services0.21%

Country exposure

Top 8

United States94.46%

United Kingdom1.65%

Netherlands1.37%

Singapore0.88%

Canada0.84%

Uruguay0.44%

Ireland0.23%

Other0.13%

Fund income

Distributions

Ex-dividend dateRecord datePayment dateAmount

Jun 24, 2026

Record date

Jun 24, 2026

Payment date

Jun 30, 2026

Jun 24, 2026

Jun 30, 2026

$0.077

Quarterly

Mar 25, 2026

Record date

Mar 25, 2026

Payment date

Mar 31, 2026

Mar 25, 2026

Mar 31, 2026

$0.088

Quarterly

Dec 24, 2025

Record date

Dec 24, 2025

Payment date

Dec 31, 2025

Dec 24, 2025

Dec 31, 2025

$0.165

Quarterly

Sep 24, 2025

Record date

Sep 24, 2025

Payment date

Sep 30, 2025

Sep 24, 2025

Sep 30, 2025

$0.0379

Irregular

Latest coverage

QB news

businesswire.com·Sep 9, 2026

Guided Therapeutics Reaches Collaborative Agreement with Türkiye's Ministry of Health to Become Primary Screening Test for Cervical Cancer

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that it has reached an agreement with the Ministry of Health to co-develop…

Read source

businesswire.com·Jul 22, 2026

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner…

Read source

businesswire.com·Jul 14, 2026

Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had reached a new agreement with Yuanshuo Medical Instruments Corporation…

Read source

More funds

Explore more ETFs

Browse all ETFs

Vanguard Total International Stock ETF

VXUS

$86.28

-1.29%

Invesco QQQ Trust, Series 1

QQQ

$708.69

-1.06%

BNY Mellon Municipal Opportunities ETF

BMOP

$24.00

-1.11%

Vanguard Total Bond Market ETF

BND

$71.27

-0.64%

SPAC and New Issue ETF

SPCK

$22.0499

-0.50%

Vanguard Total International Bond ETF

BNDX

$46.965

-0.56%

ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.